On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
On April 30, 1998, the Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for the…
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
In 1998, The University of Minnesota Cancer Center, which was founded in 1991, was renamed the Masonic Cancer…
In 1998, the The Prostate Centre at VGH, now known as the Vancouver Prostate Centre, was founded. The…
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
In 1998, the Mammography Quality Standards Reauthorization Act (MQSA) was passed by the U.S. Congress and continued the…
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
In 1998, The Case Cancer Center (Case CCC) was recognized as an National Cancer Institute (NCI)-designated comprehensive cancer…
In 1998, the Centers for Disease Control and Prevention (CDC) reported that an estimated 47.2 million adults (24.1%),…
On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
On Jul. 29, 1997, the National Cancer Institute (NCI) released information that nuclear testing during the 1950s could…
On Jul. 23, 1997, Richard D. Klausner, M.D., director of the National Cancer Institute (NCI) announced the creation…
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
In 1997, the Cancer Genome Anatomy Project (CGAP), created by the National Cancer Institute (NCI), is a multi-year…
In 1997, the National Cancer Institute (NCI) and Chinese scientists found that occupational exposure to benzene is associated…
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…
In 1997, the University of Colorado Cancer Center (CU) at the Anschutz Medical Campus received National Cancer Institute…
In 1997, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its National Cance Institute ‘comprehensive’…
In 1997, a mouse model of promyelocytic leukemia was developed by Washington University – St. Louis researcher Timothy…
In 1997, planning began for Oregon Health & Science University’s (OHSU) Center for Women’s Health, and an interim…
In 1997, the Oregon Cancer Center was established with a grant from the National Cancer Institute (NCI) of…
In 1997, Oregon Health & Science University (OHSU) announced that the institute achieved National Cancer Institute (NCI) designation,…
In 1997, the Huntsman Cancer Institute received National Comprehensive Cancer Network (NCCN) designation. In 1995, the Center earned…
In 1997, IsoRay was founded in Richland as a spin-off from the Pacific Northwest National Laboratory (PNNL) to…